Scholar Rock names new CEO, adds biotech veterans in C-suite rebuild

As it awaits an FDA approval decision, Scholar Rock is reshaping its leadership team with industry veterans. Current CEO Jay Backstrom is departing the Cambridge, MA-based drug developer in a "planned transition." David Hallal, who ...